All In Biotech

Drug Trial Radar · NCT03726658

Zelquistinel in the Treatment of Adults With Major Depressive Disorder

A Two-Part, Double-Blind, Placebo-Controlled, Single- and Multiple-Dose (Part A) or Twice Daily Dose (Part B) Study of AGN-241751 in Adult Participants With Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Apr 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 226 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

226

Actual

Start

Nov 8, 2018

Primary completion

Oct 23, 2019

Study completion Oct 23, 2019

Sponsor

Lead sponsor
Syndeio Biosciences, IncIndustry
Sponsor type
Industry
First posted
Oct 31, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of AGN-241751 in participants with Major Depressive Disorder

Conditions

  • Major Depressive Disorder

Interventions

  • AGN-241751Drug

    AGN-241751 is supplied in tablet form

  • PlaceboDrug

    Placebo is supplied in tablet form

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Change in MADRS Score at 1 Day the Initial Dose of AGN-241751 Reported as Change From Baseline in Treated Group Compared With Change From Baseline in Placebo GroupTime frame: Baseline (Day1) to Day 2
  2. Part B: Change From Baseline in MADRS Score at Day 8 Post the Initial Dose of AGN-241751 (i.e. 1 Day After the Seventh Daily Dose)Time frame: Baseline (Day 1) to Day 8

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Alea Research

    Phoenix, Arizona

  • Collaborative Neuroscience Network, LLC

    Garden Grove, California

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • Hassman Research Institute

    Berlin, New Jersey

  • Northwest Clinical Research Center

    Bellevue, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.